Browse 56 myasthenia gravis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Myasthenia Gravis is a chronic autoimmune neuromuscular disorder that causes muscle weakness and fatigue, often affecting the eyes, face, swallowing, speech, and breathing muscles. Symptoms may include drooping eyelids, double vision, difficulty speaking, and weakness that worsens with activity. Clinical trials for Myasthenia Gravis explore new therapies aimed at improving muscle function, reducing immune system attacks, and managing symptoms more effectively. Myasthenia Gravis may be connected to conditions like Autoimmune Disorders, Neurological Disorders, Multiple Sclerosis, and Chronic Fatigue — explore related condition trials below.